SG
Sangamo Therapeutics, Inc.
SGMOQ · OTC
$0.14 -2.20% (-$0.00)
1M -9.44%
Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
42 /100
Moderate Beta 1.40x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SGMOQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alexander D. Macrae
Employees
142
Headquarters
Richmond
Upcoming events
28 SEP
Earnings
Upcoming earnings report
29 OCT
Earnings
Upcoming earnings report